BioPlus Acquisition Corp. (BIOS)
BioPlus Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $10.79, down 0.05% on the session, giving a market capitalisation of $209.1M. On trailing twelve-month figures it carries a trailing P/E of 53.98, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.
BioPlus Acquisition Corp. is most often compared with the following Financial Services names: